Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.

Journal of clinical pathology - 1 Oct 2015

Akhter Ariz, Mahe Etienne, Street Lesley, Pournazari Payam, Perizzolo Marco, Shabani-Rad Meer-Taher, Stewart Douglas A, Mansoor Adnan

Abstract excerpt

BACKGROUND: Mantle cell lymphoma (MCL) is an aggressive disease with genetic heterogeneity and discrete clinical subtypes. MCL is rarely CD10 positive. These cases raise the question whether a subset of MCL may be germinal centre (GC) derived, and have distinct clinicopathological characteristics. AIMS AND METHODS: A series of nine CD10-positive MCL cases is described herein. The clinicopathological and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cluster Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Immunophenotyping

Share to Lymphoma, Mantle-Cell

Share to Neprilysin

Share to Predictive Value of Tests

Share to Registries

Source

Identifiers

PMID: 26124315
DOI: 10.1136/jclinpath-2015-202955

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.PMID 26124315Read ↗

Mantle cell lymphoma with aberrant expression of CD10Semantic proximity Read ↗

Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.Semantic proximity Read ↗

Biological and clinical determinants shaping heterogeneity in mantle cell lymphomaSemantic proximity Read ↗

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell LymphomaSemantic proximity Read ↗

Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.Semantic proximity Read ↗

Mantle cell lymphoma: recent insights into pathogenesis, clinical variability, and new diagnostic markersSemantic proximity Read ↗

Aberrant expression of CD 10 and BCL 6 in mantle cell lymphomaSemantic proximity Read ↗

Mantle cell lymphoma pathology update in the 2016 WHO classificationSemantic proximity Read ↗

The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.Semantic proximity Read ↗

BCL6, MUM1, and CD10 expression in mantle cell lymphoma.Semantic proximity Read ↗

Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.Semantic proximity Read ↗

Molecular Pathogenesis of Mantle Cell Lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.